Publication November 9, 2026

Cerebrolysin Study on S100B Levels Post-Hemorrhage Published

A new study on cerebrolysin was published on November 9, 2026, in the Journal of Clinical Medicine. The publication is titled "Longitudinal Serum and Cerebrospinal Fluid S100B Concentrations After Aneurysmal Subarachnoid Hemorrhage: An Exploratory Comparison of Historical Cohorts With and Without Cerebrolysin Exposure." The study describes an exploratory comparison of historical cohorts, examining S100B concentrations in both serum and cerebrospinal fluid over time following aneurysmal subarachnoid hemorrhage. Cohorts were divided based on prior cerebrolysin exposure. Cerebrolysin remains classified as an unapproved compound for research purposes. No findings, outcomes, or conclusions from this publication have been provided beyond its title and subject matter. The listing indicates this is a new addition to the scientific literature on cerebrolysin in the context of subarachnoid hemorrhage research. Readers interested in the broader background and research context of cerebrolysin can consult the compound overview for additional information.

See the full cerebrolysin overview

Source: https://pubmed.ncbi.nlm.nih.gov/43030876/